Viewing Study NCT03791060


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2026-02-25 @ 4:47 PM
Study NCT ID: NCT03791060
Status: TERMINATED
Last Update Posted: 2024-05-17
First Post: 2018-12-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Secukinumab for NLD (Cosentyx) in Patients With Necrobiosis Lipoidica Diabeticorum (NLD)
Sponsor: Beth Israel Deaconess Medical Center
Organization: